A composition is disclosed for the treatment of infections caused bypathogenic agents, such as bacteria, fungi, or yeasts.In particular, the composition according to the invention comprises asynergistic association of two peptides, namely lactoferricin andlactoferrampin, which has been shown to be significantly active against suchpathogenic agents.